Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.
- NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_assertion description "[We have previously shown that glucose-dependent insulinotropic polypeptide (GIP) analogues that originally have been developed to treat diabetes have neuroprotective effects in the brains of the APPswe/PS1?E9 mouse model of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.
- NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_assertion evidence source_evidence_literature NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.
- NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_assertion SIO_000772 23568101 NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.
- NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_assertion wasDerivedFrom befree-20150227 NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.
- NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_assertion wasGeneratedBy ECO_0000203 NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP425282.RA_CRU7ey6CIJPxXigy2KraZVw6_BgC4aFQOdJWdAMJKg130_provenance.